{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:32:10Z","timestamp":1789475530864,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ejso.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T07:16:29Z","timestamp":1497683789000},"page":"1572-1580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A\u00a0propensity score-matched study"],"prefix":"10.1016","volume":"43","author":[{"given":"F.","family":"Favi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bollschweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berlth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Plum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Hescheler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Alakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Semrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.P.","family":"M\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Drebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"H\u00f6lscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2017.06.003_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2017.06.003_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO;2-L","article-title":"Demographic variations in the rising incidence of esophageal adenocarcinoma in white males","volume":"92","author":"Bollschweiler","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib3","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/ijc.23691","article-title":"Trends in esophageal cancer incidence by histology, United States, 1998-2003","volume":"123","author":"Trivers","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib4","first-page":"25","article-title":"Cardia cancer: attempt at a therapeutically relevant classification","volume":"58","author":"Siewert","year":"1987","journal-title":"Chirurg"},{"key":"10.1016\/j.ejso.2017.06.003_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1200\/JCO.2010.33.0597","article-title":"Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial","volume":"29","author":"Ychou","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S1470-2045(11)70142-5","article-title":"Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis","volume":"12","author":"Sjoquist","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","article-title":"Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer","volume":"355","author":"Cunningham","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2017.06.003_bib9","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.ejca.2012.07.029","article-title":"Highlights of the EORTC St. gallen international expert consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer","volume":"48","author":"Lutz","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/bjc.2012.588","article-title":"Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer","volume":"108","author":"Lorenzen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12032-016-0774-4","article-title":"A\u00a0pilot trial of FLOT neoadjuvant chemotherapy for resectable esophagogastric junction adenocarcinoma","volume":"33","author":"Al-Fakeeh","year":"2016","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib12","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S1470-2045(16)30531-9","volume":"17","author":"Al-Batran","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib13","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2017.06.003_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/SLA.0000000000000964","article-title":"Prognostic classification of histopathologic response to neoadjuvant therapy in esophageal adenocarcinoma","volume":"260","author":"Holscher","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.06.003_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.sla.0000245847.40779.10","article-title":"Laparoscopic ischemic conditioning of the stomach for esophageal replacement","volume":"245","author":"H\u00f6lscher","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.06.003_bib16","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/SLA.0000000000000335","article-title":"What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy","volume":"260","author":"Kutup","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.06.003_bib17","series-title":"TNM-Klassifikation maligner Tumoren","author":"Wittekind","year":"2010"},{"key":"10.1016\/j.ejso.2017.06.003_bib18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/01.sla.0000186170.38348.7b","article-title":"Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification","volume":"242","author":"Schneider","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.06.003_bib19","doi-asserted-by":"crossref","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","article-title":"Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer","volume":"27","author":"Allum","year":"2009","journal-title":"J\u00a0Clin Oncol Offic J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib20","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(02)08651-8","article-title":"Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial","volume":"359","author":"MRCOCWG","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2017.06.003_bib21","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJM199812313392704","article-title":"Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer","volume":"339","author":"Kelsen","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2017.06.003_bib22","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2006.10.4760","article-title":"Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer","volume":"25","author":"Kelsen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib23","series-title":"ASCO annual meeting. Chicago, IL","article-title":"Neoadjuvant chemotherapy for resectable oesophageal and junctional adenocarcinoma: results from the UK medical research council randomised OEO5 trial (ISRCTN 01852072)","author":"Alderson","year":"2015"},{"key":"10.1016\/j.ejso.2017.06.003_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1055\/s-0041-107381","article-title":"S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des \u00d6sophagus (Langversion 1.0-September 2015, AWMF-Registernummer: 021\/023OL)","volume":"53","author":"Porschen","year":"2015","journal-title":"Zeitschrift fur Gastroenterol"},{"key":"10.1016\/j.ejso.2017.06.003_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00104-016-0214-1","article-title":"Die neue S3-Leitlinie zum \u00d6sophaguskarzinom. Wichtige chirurgische Aspekte","volume":"87","author":"H\u00f6lscher","year":"2016","journal-title":"Chirurg"},{"key":"10.1016\/j.ejso.2017.06.003_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/annonc\/mdw010","article-title":"A\u00a0randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction","volume":"27","author":"Klevebro","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2008.17.0506","article-title":"Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction","volume":"27","author":"Stahl","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejca.2010.09.009","article-title":"Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial","volume":"47","author":"Burmeister","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/annonc\/mdw560","article-title":"Multimodality treatment for esophageal adenocarcinoma: multi-center propensity-score matched study","volume":"28","author":"Markar","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2017.06.003_bib30","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/ijc.26180","article-title":"Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel","volume":"130","author":"Homann","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ijc.29403","article-title":"NeoFLOT: multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-very good response predominantly in patients with intestinal type tumors","volume":"137","author":"Schulz","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2017.06.003_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12885-016-2564-y","article-title":"ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)","volume":"16","author":"Hoeppner","year":"2016","journal-title":"BMC Cancer"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317305437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317305437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T09:47:16Z","timestamp":1602323236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317305437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0748798317305437"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.06.003","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A\u00a0propensity score-matched study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}